InspireMD, Inc. (NSPR) stock
NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3054% below fair value
$0.65+0.05 (+8.33%)
Close on Nov 17, 2026Market cap $30.22MP/E –Yield –
InspireMD revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
InspireMD's revenue for the twelve months ending Jun 30, 2026 was $10.84M, up 53.4% year over year. For fiscal 2025 it was $8.98M, up 28.1% from the year before. Over ten years it grew 14.5% a year on average. The highest annual figure on record is $8.98M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.98M | +28.1% |
| FY2024 | Dec 31, 2024 | $7.01M | +13.0% |
| FY2023 | Dec 31, 2023 | $6.21M | +20.0% |
| FY2022 | Dec 31, 2022 | $5.17M | +15.0% |
| FY2021 | Dec 31, 2021 | $4.50M | +80.9% |
| FY2020 | Dec 31, 2020 | $2.49M | -33.2% |
| FY2019 | Dec 31, 2019 | $3.72M | +3.3% |
| FY2018 | Dec 31, 2018 | $3.60M | +30.4% |
| FY2017 | Dec 31, 2017 | $2.76M | +45.8% |
| FY2016 | Dec 31, 2016 | $1.89M | -18.0% |
| FY2015 | Dec 31, 2015 | $2.31M | -52.6% |
| FY2013 | Jun 30, 2013 | $4.87M | -1.5% |
| FY2010 | Dec 31, 2010 | $4.95M | +45.1% |
| FY2009 | Dec 31, 2009 | $3.41M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.77M | -0.4% |
| Q1 FY2026 | Mar 31, 2026 | $3.40M | +122.2% |
| Q4 FY2025 | Dec 31, 2025 | $3.15M | +61.6% |
| Q3 FY2025 | Sep 30, 2025 | $2.52M | +39.4% |
| Q2 FY2025 | Jun 30, 2025 | $1.78M | +2.2% |
| Q1 FY2025 | Mar 31, 2025 | $1.53M | +1.2% |
| Q4 FY2024 | Dec 31, 2024 | $1.95M | +10.7% |
| Q3 FY2024 | Sep 30, 2024 | $1.81M | +16.3% |
| Q2 FY2024 | Jun 30, 2024 | $1.74M | +5.5% |
| Q1 FY2024 | Mar 31, 2024 | $1.51M | +22.0% |
| Q4 FY2023 | Dec 31, 2023 | $1.76M | +71.6% |
| Q3 FY2023 | Sep 30, 2023 | $1.56M | +8.7% |
| Q2 FY2023 | Jun 30, 2023 | $1.65M | +7.7% |
| Q1 FY2023 | Mar 31, 2023 | $1.24M | +4.7% |
| Q4 FY2022 | Dec 31, 2022 | $1.03M | -25.7% |
| Q3 FY2022 | Sep 30, 2022 | $1.43M | +33.6% |
| Q2 FY2022 | Jun 30, 2022 | $1.53M | +47.5% |
| Q1 FY2022 | Mar 31, 2022 | $1.18M | +17.6% |
| Q4 FY2021 | Dec 31, 2021 | $1.38M | +773.4% |
| Q3 FY2021 | Sep 30, 2021 | $1.07M | +9.3% |
| Q2 FY2021 | Jun 30, 2021 | $1.04M | +231.6% |
| Q1 FY2021 | Mar 31, 2021 | $1.01M | -2.7% |
| Q4 FY2020 | Dec 31, 2020 | $158.00K | -84.4% |
| Q3 FY2020 | Sep 30, 2020 | $980.00K | +4.4% |
| Q2 FY2020 | Jun 30, 2020 | $313.00K | -76.9% |
| Q1 FY2020 | Mar 31, 2020 | $1.03M | +149.2% |
| Q4 FY2019 | Dec 31, 2019 | $1.01M | +23.2% |
| Q3 FY2019 | Sep 30, 2019 | $939.00K | +22.1% |
| Q2 FY2019 | Jun 30, 2019 | $1.35M | +35.0% |
| Q1 FY2019 | Mar 31, 2019 | $415.00K | -58.8% |
| Q4 FY2018 | Dec 31, 2018 | $822.00K | -1.4% |
| Q3 FY2018 | Sep 30, 2018 | $769.00K | +7.1% |
| Q2 FY2018 | Jun 30, 2018 | $1.00M | +56.7% |
| Q1 FY2018 | Mar 31, 2018 | $1.01M | +77.0% |
| Q4 FY2017 | Dec 31, 2017 | $834.00K | +159.0% |
| Q3 FY2017 | Sep 30, 2017 | $718.00K | +53.1% |
| Q2 FY2017 | Jun 30, 2017 | $640.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $569.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $322.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $469.00K | – |
See a number that looks wrong?